Resveratrol and Ophthalmic Diseases

被引:132
|
作者
Abu-Amero, Khaled K. [1 ,2 ]
Kondkar, Altaf A. [2 ]
Chalam, Kakarla V. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA
[2] King Saud Univ, Coll Med, Dept Ophthalmol, Glaucoma Res Chair, Riyadh 11424, Saudi Arabia
关键词
age-related macular degeneration; cataract; diabetic retinopathy; eye; glaucoma; ocular disease; phytochemicals; PIGMENT EPITHELIAL-CELLS; INDUCED OXIDATIVE STRESS; FACTOR-KAPPA-B; TRANS-RESVERATROL; NITRIC-OXIDE; RED WINE; TISSUE DISTRIBUTION; IN-VITRO; CANCER; ACTIVATION;
D O I
10.3390/nu8040200
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Resveratrol, a naturally occurring plant polyphenol found in grapes, is the principal biologically active component in red wine. Clinical studies have shown that resveratrol due to its potent anti-oxidant and anti-inflammatory properties are cardio-protective, chemotherapeutic, neuroprotective, and display anti-aging effects. Oxidative stress and inflammation play a critical role in the initiation and progression of age-related ocular diseases (glaucoma, cataract, diabetic retinopathy and macular degeneration) that lead to progressive loss of vision and blindness. In vitro and in vivo (animal model) experimental studies performed so far have provided evidence for the biological effects of resveratrol on numerous pathways including oxidative stress, inflammation, mitochondrial dysfunction, apoptosis, pro-survival or angiogenesis that are implicated in the pathogenesis of these age-related ocular disorders. In this review, we provide a brief overview of current scientific literature on resveratrol, its plausible mechanism(s) of action, its potential use and current limitations as a nutritional therapeutic intervention in the eye and its related disorders.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Resveratrol and Calcium Signaling: Molecular Mechanisms and Clinical Relevance
    McCalley, Audrey E.
    Kaja, Simon
    Payne, Andrew J.
    Koulen, Peter
    MOLECULES, 2014, 19 (06): : 7327 - 7340
  • [22] Bevacizumab for ophthalmic diseases
    Michels, Stephan
    Prager, Franz
    Bakri, Sophie J.
    Wacht, Joachim
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (03) : 369 - 378
  • [23] Indian traditional medicinal plants in ophthalmic diseases
    Nafees, Sana
    Akhtar, Jamal
    Kaur, Jasbir
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2022, 12 (06) : 566 - 575
  • [24] Cellular senescence and ophthalmic diseases: narrative review
    Soleimani, Mohammad
    Cheraqpour, Kasra
    Koganti, Raghuram
    Djalilian, Ali R. R.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (11) : 3067 - 3082
  • [25] Cellular senescence and ophthalmic diseases: narrative review
    Mohammad Soleimani
    Kasra Cheraqpour
    Raghuram Koganti
    Ali R. Djalilian
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 3067 - 3082
  • [26] Resveratrol and Cardiovascular Diseases
    Bonnefont-Rousselot, Dominique
    NUTRIENTS, 2016, 8 (05)
  • [27] Cardiovascular effects of resveratrol
    Bukarica, Ljiljana Gojkovic
    Protic, Dragana
    Kanjuh, Vladimir
    Heinle, Helmut
    Novakovic, Radmila
    Scepanovic, Radisav
    VOJNOSANITETSKI PREGLED, 2013, 70 (12) : 1145 - 1150
  • [28] Effects of resveratrol on mitochondrial biogenesis and physiological diseases
    Uriho, Angelo
    Tang, Xue
    Le, Guowei
    Yang, Shaojun
    Harimana, Yves
    Ishimwe, Steven Papy
    Lu, Yiping
    Zhang, Kai
    Ma, Shuhua
    Muhoza, Bertrand
    ADVANCES IN TRADITIONAL MEDICINE, 2021, 21 (01) : 1 - 14
  • [29] Ophthalmic Nanosystems with Antioxidants for the Prevention and Treatment of Eye Diseases
    Dinte, Elena
    Vostinaru, Oliviu
    Samoila, Ovidiu
    Sevastre, Bogdan
    Bodoki, Ede
    COATINGS, 2020, 10 (01)
  • [30] Pharmacoeconomics of new medications for common chronic ophthalmic diseases
    Hirsch, Jan D.
    Morello, Candis
    Singh, Renu
    Robbins, Shira L.
    SURVEY OF OPHTHALMOLOGY, 2007, 52 (06) : 618 - 633